Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA
Warren, Luigi, Manos, Philip D., Ahfeldt, Tim, Loh, Yuin-Han, Li, Hu, Lau, Frank, Ebina, Wataru, Mandal, Pankaj K. +8 more·2010·Cell Stem Cell
Cited by (1,006)
Items 1,001–1,006 of 1,006
- The business of exploiting induced pluripotent stem cellsCatherine D. Prescott · 2011 · Philosophical Transactions of the Royal Society B Biological Sciences
- Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promotersHao Chen, Qisheng Zuo, Yingjie Wang, Jiuzhou Song, Huilin Yang, Yani Zhang, Bichun Li · 2017 · BMC Biotechnology
- Pieter Cullis’ quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?Tam, Ying K., Madden, Thomas D., Hope, Michael J. · 2016 · Journal of Drug Targeting
- Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver DevelopmentFeng, Lei, Wang, Yi, Fu, Yu, Li, Ting, He, Guolin · 2024 · Stem Cell Reviews and Reports
- Mouse Pluripotent Stem Cell Differentiation Under Physiological Oxygen Reduces Residual TeratomasMillman, Jeffrey R., Tan, Jit Hin, Colton, Clark K. · 2021 · Cellular and Molecular Bioengineering
- Human iPSC Models in Drug Discovery: Opportunities and ChallengesSilva, M.C., Cross, A., Brandon, N.J., Haggarty, S.J. · 2017 · Comprehensive Medicinal Chemistry III